Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy GlycoMimetics (GLYC) stocks in Canada
Learn how to easily invest in GlycoMimetics stocks.
GlycoMimetics is a biotechnology business based in the US. GlycoMimetics stocks (GLYC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.16 – a decrease of 5.83% over the previous week. GlycoMimetics employs 54 staff and has a trailing 12-month revenue of around $1.3 million.
How to buy shares in GlycoMimetics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GLYC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in GlycoMimetics?
- Has coronavirus impacted GlycoMimetics shares?
- GlycoMimetics shares summary
- Compare share dealing platforms
- Is GlycoMimetics stock a buy or sell?
- GlycoMimetics performance over time
- GlycoMimetics's financials
- How volatile are GlycoMimetics shares?
- Does GlycoMimetics pay a dividend?
- Other common questions
GlycoMimetics stock price (NASDAQ:GLYC)Use our graph to track the performance of GLYC stocks over time.
GlycoMimetics shares at a glance
|Latest market close||$1.13|
|52-week range||$1.02 - $4.40|
|50-day moving average||$1.59|
|200-day moving average||$2.07|
|Wall St. target price||$9.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.22|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy GlycoMimetics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
GlycoMimetics price performance over time
|1 week (2022-01-19)||-5.83%|
|1 month (2021-12-22)||N/A|
|3 months (2021-10-26)||-41.15%|
|6 months (2021-07-26)||-44.61%|
|1 year (2021-01-26)||-71.96%|
|2 years (2020-01-24)||-75.22%|
|3 years (2019-01-25)||10.81|
|5 years (2017-01-26)||5.57|
|Revenue TTM||$1.3 million|
|Gross profit TTM||$10.2 million|
|Return on assets TTM||-29.8%|
|Return on equity TTM||-52.44%|
|Market capitalisation||$57.4 million|
TTM: trailing 12 months
GlycoMimetics share dividends
We're not expecting GlycoMimetics to pay a dividend over the next 12 months.
GlycoMimetics share price volatility
Over the last 12 months, GlycoMimetics's shares have ranged in value from as little as $1.015 up to $4.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GlycoMimetics's is 1.8429. This would suggest that GlycoMimetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
GlycoMimetics, Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359 to target E-selectin and a chemokine receptors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin; and Galectin-3, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and collaboration and license agreement with Apollomics for the development and commercialization of uproleselan and GMI-1687.
Stocks similar to GlycoMimetics
GlycoMimetics in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.